Get the app!
Back to Companies

Caribou Biosciences, Inc.

CRBUNasdaqCIK: 0001619856

Recent Form 4 activity at Caribou Biosciences, Inc. (CRBU) spans 13 filings across 13 insiders (all of them on the sell side). Purchases total $0 against $35.5K in sales — heavily weighted toward selling, for net sales of $35.5K. Haurwitz Rachel E. (President and CEO, Director) is the most active by dollar volume, and the single largest transaction was $1.2M by Haurwitz Rachel E.. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.

Total Volume
$3.8M
Purchases
$0
Sales
$35.5K
Unique Insiders
13

Recent Insider Trades

13 loaded
Feb 20CRBU
Caribou Biosciences, Inc.
JOHNSON DAVID LEEDirectorAward$81.0K
Feb 24CRBU
Caribou Biosciences, Inc.
Kelly Timothy PChief Technology OfficerSell$6.2K
Feb 24CRBU
Caribou Biosciences, Inc.
Albertson Tina M.Chief Medical OfficerSell$2.1K
Feb 20CRBU
Caribou Biosciences, Inc.
Braunstein ScottDirectorAward$81.0K
Feb 24CRBU
Caribou Biosciences, Inc.
MCCLUNG BARBARA GChief Legal OfficerSell$13.6K
Feb 20CRBU
Caribou Biosciences, Inc.
Ryali SriramChief Financial OfficerGrant$445.5K
Feb 20CRBU
Caribou Biosciences, Inc.
Sacks NatalieDirectorAward$81.0K
Feb 20CRBU
Caribou Biosciences, Inc.
Haurwitz Rachel E.President and CEO, DirectorGrant$1.2M
Feb 20CRBU
Caribou Biosciences, Inc.
GUGGENHIME ANDREWDirectorAward$81.0K
Feb 24CRBU
Caribou Biosciences, Inc.
Khan Ruhi AhmadChief Business OfficerSell$13.6K
Feb 20CRBU
Caribou Biosciences, Inc.
Richardson-Heron DaraDirectorAward$81.0K
Feb 20CRBU
Caribou Biosciences, Inc.
Whiting NancyDirectorAward$81.0K
Feb 20CRBU
Caribou Biosciences, Inc.
Zheng RanDirectorAward$81.0K

13 filings